Question to the Department for Business, Energy and Industrial Strategy:
To ask Her Majesty's Government what assessment they have made of reports that decision-making by the UK Vaccine Task Force relating to COVID-19 vaccines has been delayed by the civil service.
The Vaccine Taskforce has made, and continues to make, decisions rapidly to tackle COVID-19 and its variants. This has been recognised by the Public Accounts Committee in its recent report, that “the Department for Business, Energy and Industrial Strategy, NHS England and NHS Improvement, and Public Health England have made major and world beating progress in buying and starting to roll-out the vaccines.”
The Vaccine Taskforce has worked at pace, resulting in the UK being the first country to procure, authorise, and deploy the Pfizer/BioNTech and Oxford University/AstraZeneca vaccines. This is the largest immunisation programme in UK history and, as of 23 February, over 17.5 million people in the UK have received the first dose of a COVID-19 vaccine. This has been alongside various other achievements within the past 11 months, including: